Columbus CyberKnife strives to be a resource for prostate cancer patients looking to find out more about how CyberKnife® treatment can benefit them. Below are some common questions and answers about the CyberKnife technology.
What sets CyberKnife apart from other treatment options?
A major advantage of this technology is its ability to offer patients a noninvasive treatment option without impeding on their lifestyle. CyberKnife treats prostate cancer patients in five or fewer sessions, allowing patients to return to their normal routines immediately following each session. The accuracy of treatment also reduces side effects associated with other forms of treatment for prostate cancer.
How is SBRT with CyberKnife different from conventional radiation therapy?
CyberKnife has the ability to directly target the prostate while compensating for patient and prostate movement during treatment. This technology minimizes radiation exposure to surrounding healthy tissue. Since CyberKnife treatment for prostate cancer is completed within five sessions over a period lasting one to two weeks, treatment time is also significantly shorter than traditional radiation therapy, which can last up to eight weeks.
Is SBRT more expensive than other treatment options?
No. A study titled “Cost-Effectiveness Analysis of SBRT Versus IMRT” compared the cost of SBRT and IMRT for treatment of low- to intermediate-risk prostate cancer. The study revealed that on average the cost of SBRT was nearly $14,000 less than IMRT. You can learn more about the study here.
CyberKnife offers several benefits for patients, particularly those related to quality of life issues that may be dramatically impacted by conventional surgery. To find out if you are a candidate for CyberKnife treatment, contact our center.
This is not intended as medical advice to replace the expertise and judgment of your health care team. It is intended to help you and your family make informed decisions, together with your doctor.